Home Search Abstracts View Session E-mail Abstract Author


Session 159 Poster Abstracts
Hepatitis C Acute HCV Infection: Epidemiology and Immunology
Session Day and Time: Monday, 1 - 4 pm
Poster Hall


889
Portal Fibrosis during Acute HCV Infection of HIV-infected Men
Daniel Fierer*, A Uriel, D Carriero, A Klepper, D Dieterich, M Mullen, S Thung, I Fiel, and A Branch
Mt Sinai Sch of Med, New York, NY, US

Background:  Multiple outbreaks of acute hepatitis C virus (HCV) infection have recently been reported in HIV-infected men who have sex with men (MSM).  The extent of liver disease in these patients is unknown and is of concern.

Methods:  After providing informed consent, we enrolled in a prospective study of acute HCV infection, 4 consecutive HIV-infected MSM referred to Mount Sinai for the treatment of acute HCV infection.

Results:  All 4 patients had acute HCV infection confirmed using the following criteria (see the table):  alanine aminotransferase (ALT) elevations of >10 x ULN, HCV antibody seroconversion, and widely fluctuating HCV viral load; all had clinical and laboratory findings consistent with previously reported cases of acute HCV in HIV+ MSM.  Liver biopsy performed within 5 months of presentation with elevated ALT levels, surprisingly, showed moderate portal fibrosis (stage 2 of 4; Scheuer) in 3 of the 4 patients (1, 2, and 3), as well as the expected findings of acute viral hepatitis in all patients; moderate central hyalin sclerosis was found in patient 4. All patients had negative evaluations for hepatitis A virus (HAV) and hepatitis B virus (HBV); all denied heavy alcohol use; and 1 had never received ART. No cause of chronic liver disease common to all patients could be identified to explain the fibrosis.

Conclusions:  Of 4 consecutively evaluated HIV-infected MSM with acute HCV infection, 3 unexpectedly had moderately advanced portal fibrosis on liver biopsy; the fourth had central hyalin sclerosis. No other cause of liver injury was identified; therefore either fibrosis during acute HCV infection is greatly accelerated by pre-existing HIV infection, or chronic liver disease of unknown etiology predated the acute HCV infection in these men. These cases suggest that HIV-infected patients presenting with acute HCV infection may already have significant liver disease, and that liver biopsy should therefore be considered in these patients.

 

1at presentation

 

 

Patient 1

Patient 2

Patient 3

Patient 4

Age (years)

40

47

40

47

Duration HIV diagnosis

4 years

13 years

17 years

11 months

CD4 count (cells/μL)1

720

303

241

697

HIV viral load (log10 copies/mL)1

<1.7

5.2

2.9

<1.7

ART history

3 years;
no ddI/d4T

never

17 years;
past ddI/d4T

11 months;
no ddI/d4T

Peak ALT (U/mL)

1,164

1,620

567

1,880

HCV viral load fluctuation

1.1 log in 2 week

2 log in 12 week

1.7 log in 4 week

2.8 log in 2 week

HCV seroconversion (mo)

4

27

34

11

HCV genotype

1a

1a

1b

1a

Pathological diagnosis

stage 2 fibrosis

stage 2 fibrosis

stage 2 fibrosis

central hyalin sclerosis